| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.1 | 0.6 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |